Chlamydia trachomatis infection

Chlamydia trachomatis infection is a sexually transmitted infection caused by the bacterium Chlamydia trachomatis, an obligate intracellular pathogen that exclusively infects humans. The organism belongs to the Chlamydiaceae family and exists in multiple serovars responsible for different clinical syndromes, including genital tract infections, ocular disease (trachoma), and lymphogranuloma venereum. The infection represents one of the most common bacterial STIs worldwide, with a substantial proportion of infected individuals remaining asymptomatic and unaware of their infection status.

The clinical presentation of Chlamydia trachomatis infection varies considerably, with approximately 70% of infected women and a significant proportion of infected men experiencing no symptoms. When symptomatic, the infection may present several weeks after exposure, with an incubation period for transmissibility estimated at two to six weeks. Women may experience vaginal discharge or dysuria, while men may present with urethral discharge, dysuria, or testicular pain and swelling. Untreated genital infections in women can ascend to the upper reproductive tract, causing pelvic inflammatory disease, which may result in chronic pelvic pain, infertility, or ectopic pregnancy. Extra-genital manifestations include reactive arthritis (the triad of arthritis, conjunctivitis, and urethritis), proctitis, and conjunctivitis. In infants born to infected mothers, the infection can cause conjunctivitis, pneumonia, and may contribute to spontaneous abortion or premature birth.

Chlamydia trachomatis infection is the most common bacterial sexually transmitted infection worldwide, imposing substantial surveillance and healthcare burdens across all regions. A distinct serovar of C. trachomatis causes trachoma, a chronic conjunctivitis that was historically the leading cause of infectious blindness globally, declining from 15% of blindness cases in 1995 to 3.6% in 2002. The infection occurs exclusively in humans, with transmission dynamics influenced by sexual behavior, access to screening and treatment, and socioeconomic factors affecting healthcare utilization. Reactive arthritis attributable to chlamydia affects approximately 15,000 men annually in the United States, with about 5,000 experiencing permanent sequelae.

Chlamydia trachomatis is transmitted through sexual contact, including vaginal, anal, and oral intercourse, as well as manual-genital contact. The infection can be transmitted from mother to infant during childbirth, with up to half of infants born to infected mothers acquiring the disease. Ocular infections may spread through direct eye-to-eye contact, contaminated towels or cloths, respiratory droplets from coughing and sneezing, and mechanical transmission by flies in areas with inadequate sanitation. The pathogen's ability to establish asymptomatic infection facilitates ongoing transmission within populations.

Sexually active individuals under 25 years of age represent the highest-risk population for chlamydia acquisition due to biological susceptibility and behavioral factors. Women have a higher risk of developing ascending genital tract infections leading to pelvic inflammatory disease and its complications. Men who have sex with men face elevated risk for extra-genital infections, particularly proctitis. Infants born to infected mothers are at risk for conjunctivitis, pneumonia, and other systemic manifestations. Populations in regions with poor sanitation are at risk for trachoma transmission, particularly where facial cleanliness cannot be maintained and fly control is inadequate.

Prevention strategies for chlamydia infection emphasize behavioral interventions including consistent condom use during sexual contact, reduction of sexual partner numbers, and regular screening of sexually active individuals. For trachoma prevention in endemic areas, the World Health Organization advocates the SAFE strategy, comprising Surgery for trichiasis, Antibiotic distribution (typically azithromycin), Facial cleanliness, and Environmental improvements to reduce fly breeding sites. Screening is recommended annually for sexually active women under 25 years of age and for older women with risk factors, though source-backed detail on specific screening recommendations is limited.

Chlamydia trachomatis infection presents unique surveillance challenges due to its predominantly asymptomatic course, which limits case detection through passive clinical reporting. Surveillance systems must rely heavily on proactive screening programs to capture infection prevalence and monitor temporal trends. The pathogen's role in multiple clinical syndromes (genital infection, trachoma, lymphogranuloma venereum, reactive arthritis) requires coordinated monitoring across different healthcare settings. Population-level surveillance should account for screening intensity variations, as increased testing may temporarily elevate reported incidence without reflecting true changes in transmission. Trend analyses should consider the proportion of infections that are asymptomatic and the potential for reinfection, which is common and may increase complication risks.

1. 1 Wikidata. Chlamydia trachomatis infections: progress and problems.
2. 2 Wikipedia. Chlamydia - Wikipedia.

ICD-10

ICD-11

Total cases

12.3M

Peak month

2015-10

Coverage

2 reporting countries · 2000-01-01 → 2026-05-09